Bay Colony Advisory Group Inc d b a Bay Colony Advisors Sells 1,599 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bay Colony Advisory Group Inc d b a Bay Colony Advisors cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 30.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,593 shares of the healthcare conglomerate's stock after selling 1,599 shares during the quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors' holdings in UnitedHealth Group were worth $1,854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. NewSquare Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $32,000. Institutional investors own 87.86% of the company's stock.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now directly owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Truist Financial reaffirmed a "buy" rating and issued a $360.00 target price (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. Deutsche Bank Aktiengesellschaft cut their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. HSBC reissued a "reduce" rating and issued a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $426.52.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $306.90 on Thursday. The stock's fifty day moving average is $370.86 and its 200 day moving average is $467.96. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $278.40 billion, a P/E ratio of 12.85, a P/E/G ratio of 1.45 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the firm posted $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.88%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.